These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16271292)

  • 1. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE).
    Skundric DS; Zhou W; Cruikshank WW; Dai R
    J Autoimmun; 2005 Nov; 25(3):206-14. PubMed ID: 16271292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.
    Piao WH; Jee YH; Liu RL; Coons SW; Kala M; Collins M; Young DA; Campagnolo DI; Vollmer TL; Bai XF; La Cava A; Shi FD
    Scand J Immunol; 2008 Jan; 67(1):37-46. PubMed ID: 18052963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent.
    Wu DM; Zhang Y; Parada NA; Kornfeld H; Nicoll J; Center DM; Cruikshank WW
    J Immunol; 1999 Feb; 162(3):1287-93. PubMed ID: 9973381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.
    Skundric DS; Cruikshank WW; Drulovic J
    J Neuroinflammation; 2015 Apr; 12():78. PubMed ID: 25896927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
    Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.
    Li J; Gran B; Zhang GX; Rostami A; Kamoun M
    J Neurol Sci; 2005 May; 232(1-2):3-9. PubMed ID: 15850576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
    Allen SJ; Baker D; O'Neill JK; Davison AN; Turk JL
    Cell Immunol; 1993 Feb; 146(2):335-50. PubMed ID: 8174174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.
    Diab A; Zhu J; Xiao BG; Mustafa M; Link H
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):641-50. PubMed ID: 9184655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis.
    Martín-Saavedra FM; Flores N; Dorado B; Eguiluz C; Bravo B; García-Merino A; Ballester S
    Mol Immunol; 2007 Jul; 44(14):3597-607. PubMed ID: 17420051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
    Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
    Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
    J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.